Contact Us
Get a quote

ESMO Immuno-Oncology & Advanced Therapies Congress 2026 | London

Queen Elizabeth II Centre, London, United Kingdom. (Broad Sanctuary, Westminster, London SW1P 3EE, United Kingdom.)

ntavis Peptide Services is pleased to participate in the ESMO Immuno-Oncology & Advanced Therapies Congress 2026, taking place from 14 to 16 December 2026, at the Queen Elizabeth II Centre in London, United Kingdom.

The ESMO Immuno-Oncology & Advanced Therapies Congress brings together the international immuno-oncology community, including researchers, clinicians, oncologists, biotechnology and pharmaceutical companies, and other experts working to advance cancer immunotherapy. The congress provides a multidisciplinary platform for scientific exchange, covering developments from basic and translational research to clinical applications, with a particular focus on advanced therapies and addressing current scientific and clinical challenges in cancer immunotherapy.

What to expect at ESMO Immuno-Oncology & Advanced Therapies Congress 2026:

  • Scientific sessions covering the latest developments in immuno-oncology and cancer immunotherapy
  • Updates on advanced therapeutic approaches and emerging immunotherapy strategies
  • Discussions on neoantigen-based cancer immunotherapy and precision immunotherapy
  • Insights into cellular therapies for solid tumors and the role of myeloid cells in cancer
  • Presentations on biomarkers, single-cell technologies, and spatial biology
  • Exploration of artificial intelligence and its potential in immuno-oncology drug development
  • Opportunities for scientific exchange, networking, and collaboration among researchers, clinicians, and industry representatives

Intavis Peptide Services looks forward to connecting with researchers, clinicians, biotechnology and pharmaceutical companies to discuss our expertise in custom peptide synthesis and peptide-based solutions for immuno-oncology research. Our services can support projects involving neoantigen research, peptide-based cancer vaccine development, immune monitoring, assay development, biomarker studies, and other applications requiring high-quality custom peptides.

Whether you are investigating neoantigens, developing peptide-based research approaches for cancer immunotherapy, working on immune-response studies, or looking for a reliable partner for custom peptide synthesis, the ESMO Immuno-Oncology & Advanced Therapies Congress 2026 offers an excellent opportunity to exchange ideas and explore potential collaborations.

We look forward to meeting you in London!

Go back

Peptides tailored to your research

Order your peptides

Click order and a form will pop-up so you can enter your sequence directly. Alternatively upload a document listing your peptides or conjugates.